World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
99
Citations
46072
World Ranking
738
National Ranking
419

Medicine

D-Index
99
Citations
46072
World Ranking
8465
National Ranking
4373

Sacha Gnjatic publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sacha Gnjatic sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 409 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sacha Gnjatic D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sacha Gnjatic sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 99 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sacha Gnjatic is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research spans multiple fields including Medicine and Biochemistry, Genetics and Molecular Biology. Their work notably intersects oncology, immunology, molecular biology, infectious diseases, and hematology.

The scientist's research topics cover a broad range of subjects related to immune responses and cancer treatment, including:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Multiple Myeloma Research and Treatments
  • COVID-19 Clinical Research Studies
  • Cancer Genomics and Diagnostics
  • SARS-CoV-2 and COVID-19 Research
  • CAR-T cell therapy research

Frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Gastroenterology
  • Journal for ImmunoTherapy of Cancer

Some of the recent significant papers authored or coauthored by Sacha Gnjatic are:

  • "An inflammatory cytokine signature predicts COVID-19 severity and survival," 2020, Nature Medicine
  • "PD-L1 as a biomarker of response to immune-checkpoint inhibitors," 2021, Nature Reviews Clinical Oncology
  • "Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)," 2020, Cell
  • "Intratumoral dendritic cell-CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma," 2023, Nature Medicine
  • "The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation," 2020, Journal for ImmunoTherapy of Cancer

Collaborations feature notable frequent coauthors, including:

  • Seunghee Kim-Schulze
  • Edgar Gonzalez-Kozlova
  • Miriam Mérad
  • Diane M. Del Valle
  • Thomas U. Marron

Best Publications

  • Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

    Eiichi Sato;Sara H. Olson;Jiyoung Ahn;Brian Bundy

  • An inflammatory cytokine signature predicts COVID-19 severity and survival.

    Diane Marie Del Valle;Seunghee Kim-Schulze;Hsin-Hui Huang;Noam D. Beckmann

  • Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

    Michael A. Postow;Margaret K. Callahan;Margaret K. Callahan;Christopher A. Barker;Christopher A. Barker;Yoshiya Yamada;Yoshiya Yamada

  • PD-L1 as a biomarker of response to immune-checkpoint inhibitors

    Deborah Blythe Doroshow;Sheena Bhalla;Mary Beth Beasley;Lynette M. Sholl

  • Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

    Vinod P. Balachandran;Marta Łuksza;Julia N. Zhao;Vladimir Makarov

  • Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

    Hélène Salmon;Juliana Idoyaga;Adeeb Rahman;Marylène Leboeuf

  • Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.

    Yonit Lavin;Soma Kobayashi;Andrew Leader;El-ad David Amir

  • Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.

    Naomi N. Hunder;Herschel Wallen;Jianhong Cao;Deborah W. Hendricks

  • Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

    Junko Matsuzaki;Sacha Gnjatic;Paulette Mhawech-Fauceglia;Amy Beck

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Radiotherapy induces responses of lung cancer to CTLA-4 blockade

    Silvia C. Formenti;Nils Petter Rudqvist;Encouse Golden;Encouse Golden;Benjamin Cooper

  • Single-cell immune landscape of human atherosclerotic plaques

    Dawn M Fernandez;Adeeb H Rahman;Nicolas F Fernandez;Aleksey Chudnovskiy

  • Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy.

    Jerome C. Martin;Christie Chang;Gilles Boschetti;Ryan Ungaro

  • Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

    Claire Germain;Sacha Gnjatic;Fella Tamzalit;Samantha Knockaert

  • Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

    Sacha Gnjatic;Djordje Atanackovic;Elke Jäger;Mitsutoshi Matsuo

  • CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

    Padmanee Sharma;Yu Shen;Sijin Wen;Sachiko Yamada

  • Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

    Elke Jäger;Sacha Gnjatic;Yasuhiro Nagata;Elisabeth Stockert

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

    Conor N. Gruber;Roosheel S. Patel;Rebecca Trachtman;Lauren Lepow

  • Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

    E Jäger;Y Nagata;S Gnjatic;H Wada

  • Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.

    Ian D. Davis;Weisan Chen;Heather Jackson;Phillip Parente;Phillip Parente

Frequent Co-Authors

Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Achim A. Jungbluth
Achim A. Jungbluth Memorial Sloan Kettering Cancer Center
Gerd Ritter
Gerd Ritter Memorial Sloan Kettering Cancer Center
Miriam Merad
Miriam Merad Icahn School of Medicine at Mount Sinai
Yao-Tseng Chen
Yao-Tseng Chen Cornell University
Nina Bhardwaj
Nina Bhardwaj Icahn School of Medicine at Mount Sinai
Kunle Odunsi
Kunle Odunsi Roswell Park Cancer Institute
Elke Jäger
Elke Jäger Goethe University Frankfurt
Jedd D. Wolchok
Jedd D. Wolchok Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often leads to diverse career paths in healthcare and research. Many students interested in expanding their expertise consider related programs like nursing, which offer specialized credentials and promising job prospects.

For those looking to advance their nursing career, exploring the cheapest psych np programs online can provide an affordable pathway to becoming a Psychiatric Nurse Practitioner. These programs focus on mental health and complement Immunology's focus on the immune system's impact on psychological well-being.

Salary expectations are crucial when planning career moves. Understanding how much do dnp nurses make can help Immunology graduates gauge financial benefits in advanced nursing roles.

For experienced nurses, there are opportunities to specialize further. Transitioning from Family Nurse Practitioner to more critical roles is possible through dedicated acnp programs, opening doors to acute care settings.

Additionally, accelerated options such as the accelerated np programs offer a faster route to qualifying as a nurse practitioner, ideal for those eager to enter the workforce swiftly.

Best Scientists Citing Sacha Gnjatic

Trending Scientists

Recently Published Articles